Erythrina alkaloids which display a variety of biological activity including hypnotic and CNS activity 1 have drawn attraction for the synthesis over the years. Some of the recent strategies on the construction of the core spirocyclic structure include intramolecular cyclization reactions such as radical cyclizations, 2 electrophilic substitution cyclizations on N-acyliminium intermediates or Pummerer-induced cyclizations, 3 Heck reactions, 4 and anionic substitution reactions.
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A few years ago, we developed a new route to the spirocyclic skeleton by palladium-catalyzed arylation of α,β-unsaturated γ-lactam. 6 In the route, the precursors for cyclization have been prepared by condensation of arylamine and keto-ester intermediates 3c under reflux in toluene in the presence of TsOH (Scheme 1).
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For the synthetic application of this method toward erythrina alkaloids, we wanted to reinvestigate the palladium catalyzed cyclization of the requsite precursor which would be formed from the condensation of ketoester 1 and bromo-arylamine 2. In the reaction, two main products were formed as shown in the Scheme 2, and the separated yields were 34% of compound 3 and 18% of compound 4. For the selective formation of each isomer, we have tried the cyclization reaction under different conditions by changing solvent, catalyst, and temperature. However, the ratio did not shift favorably for the purpose, so we considered that we had better find ways to transform each isomer to proper natural products or derivatives. It was envisioned that major intermediate 3 would be a proper precursor for erysotramidine and the minor intermediate 4 for iso-13-demethoxyerythratidinone (Scheme 2).
When the intermediate 3 was treated with Pd(OAc)2 in DBU, enol intermediate was formed in 30% yield through γ-lactam enolate formation followed by cyclization. Some amount of the corresponding ketal compound, the precursor of the enol intermediate, could be obtained if the reaction process was quenched earlier. However, the ketal interemediate was found to be reluctant to hydrolyse to ketone. Treatment of 5 with TsOH in acetone afforded compound 6 in 71% yield. Reduction of the carbonyl compound 6 under Luche condition, affording a mixture of diasteromers in 2.6 : 1 ratio, was followed by elimination to afford the known intermediate 7 for erysotramidine in 64% yield (Scheme 3).
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Meanwhile, intermediate 4 was subjected to the conventional Heck reaction, yielding the 6-membered quaternary structure 8 in 87% yield rather than 7-membered ring compound. Reduction of the amide group of 8 by LAH/AlCl3 to amine was followed by deprotection of ketal under acid to iso-13-demethoxyerythratidinone 8 in 80% in two steps. In conclusion, we have prepared two intermediates from condensation of compound 1 and 2, and suggested concise routes to the synthesis of erysotramidine and iso-13-demethoxyerythratidinone through Pd-mediated cyclization of the intermediates. C-NMR (100 MHz, CDCl3) δ 174. 1, 148.3, 148.1, 141.1, 129.6, 115.2, 113.9, 113.2, 107.8, 94.1, 64.3, 64.1, 55.9, 55.8, 39.4, 36.5, 36.1, 34.6, 32.9, 32.6. Compound 4: C-NMR (100 MHz, CDCl3) δ 171. 4, 158.3, 148.5, 148.2, 129.9, 120.7, 115.4, 113.9, 113.5, 109.5, 64.8, 64.6, 61.5, 56.1, 40.1, 38.2, 34.8, 27.7 .
(S)-3-(2-Hydroxyethoxy)-1,2,8,9-tetrahydro-11,12-dimethoxyindolo[1-a]isoquinolin-6-one (5). A mixture of 2 (548 mg, 1.25 mmol) and Pd(OAc)2 (14 mg, 0.063 mmol) in 5 mL DBU in a sealed tube was heated at 140 o C for 15 h. The reaction mixture was quenched with 40 mL aqueous HCl 2M solution, and then extracted with CH2Cl2 (30 mL × 3). The organic layers were dried over anhydrous MgSO4 and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography (EtOAc/MeOH 20:1 to 10:1) to afford 5 (132 mg, 30%) as a brownish liquid. C-NMR (100 MHz, CDCl 3 ) δ 172. 2, 163.6, 159.4, 148.1, 146.6, 128.7, 126.5, 115.0, 112.0, 108.4, 95.4, 69.5, 64.5, 60.7, 55.9, 55.8, 37.3, 33.4, 27.0, 26.9 .
(S)-1,2,8,9-Tetrahydro-11,12-dimethoxy-4H-indolo[1-a]isoquinoline-3,6-dione (6). A solution of 5 (132 mg, 0.37 mmol) and TsOH (10 mg) in acetone (10 mL) was refluxed at 60 o C for 6 h. The reaction mixture was concentrated in vacuo and the resultant residue was purified by silica gel column chromatography with EtOAc 100% to yield compound 6 (82 mg, 71%) as a yellowish liquid. 170.2, 158.3, 149.1, 146.9, 126.3, 126.1, 125.3, 113.3, 108.0, 63.8, 56.1, 56.0, 37.0, 35.1, 34.9, 33.6, 25.6 .
(S)-1,2,8,9-Tetrahydro-11,12-dimethoxyindolo[1-a]isoqui nolin-6-one (7). To a solution of 6 (82 mg, 0.26 mmol) in anhydrous MeOH was added CeCl3.7H2O (108 mg, 0.29 mmol). The mixture was stirred for 30 min before the addition of NaBH4 (11 mg, 0.29 mmol). After 3 h, the reaction mixture was extracted with EtOAc (30 mL × 3), dried over anhydrous Na2SO4 and concentrated in vacuo. The crude product was dissolved in anhydrous CH 2 Cl 2 (4 mL) followed by addition of POCl 3 (29 µL, 0.31 mmol) and DBU (191 µL, 1.3 mmol) consecutively. After 3 h, the reaction mixture was evaporated under reduced pressure and purified by silica gel column chromatography (EtOAc/ MeOH 30:1 to 15:1) to give 7 (51 mg, 64%) as a colorless liquid. C-NMR (100 MHz, CDCl3) δ 171. 2, 157.9, 148.2, 146.8, 136.0, 128.7, 126.3, 124.0, 118.9, 112.1, 108.7, 64.6, 56.0, 55.9, 37.0, 35.0, 27.2, 24.6 . C-NMR (100 MHz, CDCl3) δ 172. 9, 148.2, 147.9, 131.0, 130.3, 126.7, 126.2, 111.9, 109.3, 103.2, 64.9, 64.3, 61.1, 56.0, 55.9, 39.1, 36.1, 35.1, 34.1, 28.6. Iso-demethoxyerythratidinone (9). To a solution of anhydrous AlCl3 (60 mg, 0.45 mmol) in anhydrous THF (2 mL) at 0 o C was added 1,5 mL solution of LiAlH4 1M in THF. This solution C-NMR (100 MHz, CDCl3) δ 198. 6, 151.9, 147.9, 147.6, 129.1, 127.5, 125. 
